Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- KURUME UNIVERSITY
- Publication Date
- 2009-03-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a pharmaceutical composition for preventing, improving or treating liver fibrosis, hepatocyte degeneration or liver cirrhosis, containing a drug equivalent to glinides. Specifically, it relates to a pharmaceutical composition containing nateglinide for preventing, improving or treating liver fibrosis, hepatocyte degeneration or liver cirrhosis. Background technique
[0002] In most liver diseases such as viral hepatitis, alcoholic hepatitis, and autoimmune hepatitis, cirrhosis, the final form of liver fibrosis, leads to life-threatening diseases such as hepatocellular carcinoma, esophageal and gastric venous tumors. Therefore, there is an urgent need to establish methods for inhibiting liver fibrosis including liver cirrhosis. It has been reported that in viral hepatitis, virus depletion therapy by a combination of interferon and antiviral agent has the effect of improving fibrosis, but in Japan, even the latest combin...